Ahead of a major UN milestone, the global pharmaceutical industry has issued a “Call to Action” urging collective action across the globe to tackle the rise of non-communicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease, lung disease, mental health, and neurological disorders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311683359/en/The global pharmaceutical trade body calls on countries to enable innovati...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Christoph Korpus, PhD, MBA, as Chief Business Officer (CBO). Mr. Korpus brings more than 15 years of pharmaceutical experience to Byondis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250324077182/en/Christoph Korpus, PhD, MBA, Chief Business Officer, Byondis “Christoph ...

Circular Materials, an Italian company specialized in the recovery and valorization of metals from industrial wastewater, has been selected as a Strategic Project under the Critical Raw Materials Act, along with 3 other projects in Italy and 46 in Europe. The CRMA aims to secure European access to strategic raw materials, by increasing recycling efforts and reducing dependency on imports. Here Circular Materials plays a key role: the company’s patented innovation, SWaP (Supercritical Water Pre...